Tickers

1. Composite Trajectory Verdict

The income statement and cash flow statement carry the most weight for assessing LOAR's performance because the company's acquisition-driven growth model makes operating profitability and operating cash generation the primary indicators of whether acquired assets are being integrated effectively, while the balance sheet primarily reflects financing choices for those acquisitions.

Composite Trajectory: Mixed

Annual results show clear improvement: revenue grew from $317.5 million to $402.8 million to $496.3 million over FY 2023–2025, gross margin expanded from 48.6% to 52.7%, and net income swung from a $4.6 million loss to $72.1 million (10-K 2025-12-31, Consolidated Statements of Operations). Operating cash flow more than doubled from $55.0 million to $112.3 million over the same span (10-K 2025-12-31, Consolidated Statements of Cash Flows). However, the balance sheet has deteriorated rapidly: total debt rose from $280.7 million to $718.9 million to $952.4 million between December 2024 and June 2026, pushing debt-to-capitalization from 21% to 44% (10-K 2025-12-31, MD&A Liquidity; 10-Q 2026-06-30, MD&A Liquidity). Quarterly net income has declined year-over-year despite strong revenue growth — Q2 2026 net income was flat at $16.7 million versus $16.7 million in Q2 2025, and YTD 2026 net income fell to $27.9 million from $32.0 million — driven by a tripling of interest expense (10-Q 2026-06-30, Consolidated Statements of Operations).

2. Red Flags

• Leverage surge: Debt-to-capitalization jumped from 21% (Dec 2024) to 38% (Dec 2025) to 44% (Jun 2026) as the company funded the LMB ($445 million incremental term loan) and Harper Engineering ($240 million delayed draw) acquisitions (10-K 2025-12-31, MD&A Liquidity; 10-Q 2026-06-30, MD&A Liquidity).
• Interest expense explosion: Quarterly net interest expense rose from $6.5 million (Q2 2025) to $20.0 million (Q2 2026) and from $12.9 million (YTD 2025) to $38.7 million (YTD 2026), consuming a growing share of operating income (10-Q 2026-06-30, Consolidated Statements of Operations).
• Quarterly net income declining despite revenue growth: YTD 2026 net income fell 13% to $27.9 million while revenue grew 38% to $327.7 million; Q1 2026 net income fell 27% to $11.1 million on 36% revenue growth (10-Q 2026-06-30, Consolidated Statements of Operations; 10-Q 2026-03-31, Consolidated Statements of Operations).
• Acquisition accounting compressing margins: Gross margin dipped in Q1 2026 (50.8% vs 52.1%) and Q2 2026 (53.2% vs 53.8%) due to $4.9 million inventory step-up amortization and higher intangible amortization from LMB and Harper (10-Q 2026-03-31, MD&A Gross Profit; 10-Q 2026-06-30, MD&A Gross Profit).
• Recurring "non-recurring" acquisition costs: Transaction expenses appear in every period — $11.3 million in FY 2025, $2.8 million YTD 2026, $1.2 million Q1 2026 — and contingent consideration adjustments ($1.3 million in Q1/Q2 2026 for Harper) flow through GAAP earnings (10-K 2025-12-31, MD&A Transaction Expenses; 10-Q 2026-06-30, MD&A Transaction Expenses; 10-Q 2026-03-31, MD&A Transaction Expenses).
• Mandatory debt prepayment requirement: The Credit Agreement requires mandatory prepayments from excess cash flow, which could constrain future flexibility (10-K 2025-12-31, MD&A Credit Agreement; 10-Q 2026-06-30, Note 7).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP results show a strong improving trend over three years: net sales rose from $317.5 million (FY 2023) to $402.8 million (FY 2024) to $496.3 million (FY 2025); gross margin expanded from 48.6% to 49.4% to 52.7%; operating income grew from $69.5 million to $87.6 million to $106.2 million; and net income improved from a $4.6 million loss to $22.2 million to $72.1 million (10-K 2025-12-31, Consolidated Statements of Operations). However, the most recent quarterly comparisons show deterioration in bottom-line profitability. Q2 2026 net income was $16.7 million (9.8% margin) versus $16.7 million (13.6% margin) in Q2 2025; Q1 2026 net income was $11.1 million (7.1% margin) versus $15.3 million (13.4% margin) in Q1 2025; and YTD 2026 net income was $27.9 million (8.5% margin) versus $32.0 million (13.5% margin) in YTD 2025, despite revenue growth of 36–39% in each period (10-Q 2026-06-30, Consolidated Statements of Operations; 10-Q 2026-03-31, Consolidated Statements of Operations). The decline is attributable to sharply higher interest expense and acquisition-related amortization/step-up charges.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Operating cash flow has grown substantially on an annual basis: $12.8 million in FY 2023, $55.0 million in FY 2024, and $112.3 million in FY 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Year-to-date operating cash flow also increased to $61.2 million in the six months ended June 30, 2026 from $52.2 million in the comparable 2025 period (10-Q 2026-06-30, Consolidated Statements of Cash Flows). Capital expenditures remain modest relative to operating cash flow — $13.0 million in FY 2025 and $7.0 million YTD 2026 — yielding strong and growing free cash flow (approximately $99.3 million in FY 2025 and $54.2 million YTD 2026). Investing cash outflows are dominated by acquisitions ($520.9 million in FY 2025, $256.8 million YTD 2026), funded by corresponding financing inflows (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

The balance sheet reflects aggressive acquisition financing. Total debt increased from $280.7 million (Dec 2024) to $718.9 million (Dec 2025) to $952.4 million (Jun 2026), while debt-to-capitalization rose from 21% to 38% to 44% over the same periods (10-K 2025-12-31, MD&A Liquidity; 10-Q 2026-06-30, MD&A Liquidity). Goodwill and intangibles ballooned to $1.08 billion and $739 million respectively by June 2026, representing 78% of total assets (10-Q 2026-06-30, Consolidated Balance Sheets). Cash grew to $122.4 million (Jun 2026) from $54.1 million (Dec 2024), but remains small relative to debt. The Credit Agreement had $35 million of delayed draw capacity and $50 million revolver remaining as of June 30, 2026 (10-Q 2026-06-30, MD&A Credit Agreement). Mandatory excess-cash-flow prepayments and a 5.5x leverage covenant create near-term constraints (10-K 2025-12-31, MD&A Credit Agreement).

6. Data Gaps

• Quarterly revenue and earnings breakdowns for Q3 2025 and Q4 2025 (only Q3 2025 10-Q is referenced but not detailed in the provided filings)
• Full-year 2026 results (only six months available)
• Organic revenue growth rates for quarterly periods in XBRL format (only disclosed in MD&A narrative)
• Free cash flow for FY 2023 (capex disclosed but operating cash flow reconciliation would be needed)
• Detailed maturity schedule for the $962.9 million Credit Agreement debt outstanding at June 30, 2026
• Quantification of "excess cash flow" trigger for mandatory prepayments under the Credit Agreement